Maywufa CoTPE:1731 86 Gross Margin % is 62.50% as of Dec. 2025, which is 1% below its 10-year median of 63.36. GuruFocus rates TPE:1731 with a GF Score™ of 86/100 and a GF Value™ of NT$26.79 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 943 Drug Manufacturers companies, Maywufa Co ranks better than 73.28% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Maywufa Co's Gross Profit for the
three
months ended in Dec. 2025 was NT$259 Mil. Maywufa Co's Revenue for the
three
months ended in Dec. 2025 was NT$415 Mil. Therefore, Maywufa Co's Gross Margin % for the quarter that ended in Dec. 2025 was 62.50%.
The historical rank and industry rank for Maywufa Co's Gross Margin % or its related term are showing as below:
TPE:1731'
s Gross Margin % Range Over the Past 10 Years
Min: 42.98 Med: 63.36 Max: 66.66
Current: 63.23
During the past 13 years, the highestGross Margin % of Maywufa Co was 66.66%. The lowest was 42.98%. And the median was 63.36%.
TPE:1731's Gross Margin % is ranked better than 73.28% of 943
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs TPE:1731: 63.23
Maywufa Co had a gross margin of 62.50% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Maywufa Co was -0.30% per year.
Maywufa Co (TPE:1731) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Maywufa Co had a gross margin of 62.50% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Maywufa Co Gross Margin % Related Terms
Maywufa Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Maywufa Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Maywufa Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maywufa Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maywufa Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Maywufa Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Maywufa Co (TPE:1731) has a Gross Margin % of 62.50% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Maywufa Co and its competitors. This is near median its historical median of 63.36. Over the past decade, Maywufa Co's Gross Margin % has ranged from 42.98 to 66.66. According to the industry distribution chart, Maywufa Co ranks #252 out of 943 companies in the Drug Manufacturers industry, placing it in the top 26.7%.
Is Maywufa Co's Gross Margin % too high?
Maywufa Co's current Gross Margin % of 62.50% is near median its 10-year median of 63.36. Over the past 10 years, this metric has ranged from a low of 42.98 to a high of 66.66. The Drug Manufacturers industry median Gross Margin % is 48.54. Maywufa Co's value of 62.50% is 28.8% above this industry median. Based on the distribution chart, Maywufa Co ranks #252 out of 943 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Maywufa Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maywufa Co's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Maywufa Co ranks #252 out of 943 companies for Gross Margin %. This puts Maywufa Co in the upper half of its industry. The industry median Gross Margin % is 48.54. Maywufa Co's value of 62.50% is 28.8% above this benchmark. Historically, Maywufa Co's own Gross Margin % has ranged from 42.98 to 66.66 over the past decade. While the company's 10-year median is 63.36 vs. the industry median of 48.54, Maywufa Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maywufa Co's current Gross Margin % of 62.50% is 28.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Maywufa Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maywufa Co's current Gross Margin % is 62.50%, which is near median its own 10-year median of 63.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maywufa Co stock overvalued right now?
Based on GuruFocus' analysis, Maywufa Co (TPE:1731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$26.79, compared to a current price of NT$20.65 — trading 22.9% below its estimated fair value. The current Gross Margin % is 62.50%, which is near median its 10-year median of 63.36 and 28.8% above the Drug Manufacturers industry median of 48.54. Maywufa Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Maywufa Co (TPE:1731), the current Gross Margin % is 62.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maywufa Co (TPE:1731) Overvalued in 2026?
Based on GuruFocus' analysis, Maywufa Co stock appears to be undervalued.
The current stock price of NT$20.65 is trading 22.9% below its estimated GF Value™ of NT$26.79.
GuruFocus considers Maywufa Co to be Modestly Undervalued.
Key valuation signals for TPE:1731:
Gross Margin %: 62.50% (near median its 10-year median of 63.36)
GF Value™: NT$26.79 vs. price of NT$20.65 (22.9% below fair value)
Industry Position: 28.8% above the Drug Manufacturers median (#252 of 943)
No single metric tells the full story. See the TPE:1731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maywufa Co Ltd operates as a drug manufacturer. The company is engaged in manufacturing of hair and skin care products. The company has two reportable segments segments: Management Department, Consumer Business Unit, and Pharmaceutical Business Unit. It derives maximum revenue from Pharmaceutical Business Unit.
86GF Score
Get the complete analysis for TPE:1731
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1731 has been successfully added to your 
